EP2361089A4
(en )
2012-08-22
Compositions and methods for the treatment of altered -synuclein function
IL210153A0
(en )
2011-03-31
Nutrigenomics methods and compositions
HK1159498A1
(en )
2012-08-03
Methods and compositions for the treatment of cancer
IL212822A0
(en )
2011-07-31
Anti-cxcr1 compositions and methods
EP2249789A4
(en )
2014-01-15
Compositions and methods for the treatment of xerostomia
IL210997A0
(en )
2011-04-28
Compositions for the treatment of mrsa and uses thereof
GB0819530D0
(en )
2008-12-03
Methods and compositions
EP2331123A4
(en )
2012-11-07
Compositions and methods for the treatment of hepatitis c
EP2231665A4
(en )
2012-04-25
Novel compositions and methods of use
IL210097A0
(en )
2011-02-28
Compositions and methods for treating unfluenza
IL210559A0
(en )
2011-03-31
Novel compositions and methods
EP2340027A4
(en )
2012-04-04
Methods and compositions for the treatment of cancer
GB0718446D0
(en )
2007-10-31
Compositions and methods for the treatment of infection
IL210588A0
(en )
2011-03-31
Novel compositions and methods
HK1211472A1
(en )
2016-05-27
Compositions and methods of treatment comprising ceftaroline
GB0817585D0
(en )
2008-11-05
Novel compositions and methods
IL207827A0
(en )
2010-12-30
Apoaequorin-containing compositions and methods of using same
EP2285398A4
(en )
2012-05-30
Methods and compositions for the treatment of obesity
GB0811250D0
(en )
2008-07-30
Methods and compositions
GB0808326D0
(en )
2008-06-18
Compositions and methods for the treatment of fybromyalgia
ZA201003689B
(en )
2014-11-26
Compositions and methods for the treatment of xerostomia
GB0808730D0
(en )
2008-06-18
Compositions and methods for the prevention and treatment of schistosomiasis
EP2276502A4
(en )
2012-04-04
Compositions for the prevention and treatment of neuroinjury and methods of use thereof
IL210519A0
(en )
2011-03-31
Anti-phthiraptera treatment compositions
GB0809319D0
(en )
2008-07-02
The treatment of puritus